Cleanroom ULPA Filter Market Size, Share, Growth, and Industry Analysis, By Type ( Normal Temperature HEPA Filters,High Temperature HEPA Filters ), By Application ( Electronics,Pharma,Biotech,Medical ), Regional Insights and Forecast to 2035

Cleanroom ULPA Filter Market Overview

Global Cleanroom ULPA Filter market size, valued at USD 233.83 million in 2026, is expected to climb to USD 404.92 million by 2035 at a CAGR of 6.7%.

The Cleanroom ULPA Filter Market involves high‑performance air filtration products designed to remove ultrafine particulate contaminants down to 0.12 microns with a filtration efficiency of up to 99.9995%, essential in critical environments where air purity is mandated. ULPA filters are deployed in cleanrooms classified from ISO Class 1 through ISO Class 9 based on allowable particle counts per cubic meter, with ULPA usage increasing as cleanroom stringency tightens. In 2024, approximately 5.6 million ULPA filter units were installed in cleanroom environments globally, representing more than 32% of all cleanroom filter deployments while HEPA filters accounted for the remainder. Electronics and pharmaceutical facilities drove the highest adoption with over 3.1 million and 4.1 million filters respectively in 2024, reflecting critical contamination control needs in these sectors. The Cleanroom ULPA Filter Market Outlook shows significant activity across semiconductor fabs and biotech labs where contamination control is paramount.

In the USA Cleanroom ULPA Filter Market, demand is concentrated around semiconductor fabrication plants and pharmaceutical manufacturing cleanrooms where regulatory requirements demand ultra‑clean air. Approximately 890,000 ULPA filters were consumed in medical and pharmaceutical clean environments in 2024, accounting for roughly 16% of total global ULPA filter installations. Electronics cleanrooms in the USA also deployed more than 1.5 million units in the same period, reflecting strong domestic manufacturing activity in microelectronics and precision components. Cleanroom classifications such as ISO Class 5 and ISO Class 7 dominate facility requirements, and ULPA filters are critical in these zones for achieving particle counts below defined thresholds.

Download Free Sample to learn more about this report.

Key Findings

• High Demand in Electronics and Pharma: Electronics manufacturing cleanrooms consumed over 3.1 million ULPA filters in 2024, while pharmaceutical cleanrooms accounted for more than 4.1 million units, together representing over 70% of global installations.
• Global Installation Volume: Approximately 5.6 million ULPA filter units were installed worldwide in 2024, showing sustained demand across semiconductor fabs, biotech labs, and medical device manufacturing.
• Regional Leadership: Asia‑Pacific leads with 35% share of global ULPA filter installations, followed by North America (28%) and Europe (23%), while Middle East & Africa contributes about 6%.
• Stringent Regulatory Standards Drive Adoption: ISO Class 5–7 cleanrooms in pharmaceuticals, electronics, and biotech require ULPA filters with 99.9995% filtration efficiency, which accounts for 42% of total ULPA consumption in pharma.
• Rising Smart Filtration Adoption: Over 28% of newly installed ULPA filters now include real-time monitoring for differential pressure and end-of-life prediction, improving maintenance efficiency.
• Market Concentration: Top 5 manufacturers hold close to 50% of global production capacity, with Camfil and CLARCOR leading the segment.
• Cost as a Restraint: ULPA filters are roughly 30% more expensive than HEPA alternatives, which limits adoption in less-critical cleanroom environments.
• Growth Opportunities: Rapid expansion in semiconductor, biotech, and pharmaceutical facilities in emerging markets, particularly Southeast Asia and India, presents significant adoption potential.

Cleanroom ULPA Filter Market Latest Trends

The Cleanroom ULPA Filter Market Trends reflect heightened deployment across industries where particle control is essential. In 2024, ULPA filters represented approximately 32–35% of all cleanroom filter installations worldwide, with an estimated 5.6 million ULPA units deployed globally. Semiconductor and electronics manufacturing continued to lead consumption with more than 6.5 million cleanroom filter installations, of which over 3.1 million were ULPA filters deployed in ISO Class 1–10 cleanrooms for wafer production and precision assembly. Pharmaceutical manufacturing also drove major adoption with 4.1 million filters used in sterile drug formulation and injectable production facilities, where ULPA filters support contamination control that HEPA alone cannot achieve. Biotech applications such as biologics research labs and vaccine production required approximately 1.6 million filters, with China alone installing more than 520,000 filters in gene therapy and biosafety level facilities in 2024.

Medical device production cleanrooms accounted for about 2.7 million ULPA filters, particularly in surgical instrument and implantable device manufacturing. Additional applications included optical component assembly and aerospace cleanrooms, collectively using around 2.5 million units in 2024. ULPA filters’ ability to capture ultra‑fine contaminants at 99.9995% efficiency makes them indispensable in environments where even sub‑micron particles can compromise product integrity. Smart filtration adoption, including real‑time pressure drop sensors, now comprises more than 28% of new ULPA systems installed, aiding facility managers in optimizing filter life and maintenance schedules.

Cleanroom ULPA Filter Market Dynamics

DRIVER

"Stringent Contamination Control Standards"

Strict environmental and contamination control regulations are a key driver for the Cleanroom ULPA Filter Market Growth. Cleanrooms used in semiconductor manufacturing, pharmaceuticals, biotech, and medical device production must maintain particle counts that meet international standards like ISO Class 5 to ISO Class 9. ULPA filters, which capture airborne particles down to 0.12 microns with efficiencies up to 99.9995%, are essential in achieving and maintaining these standards. In 2024, pharmaceutical facilities accounted for more than 42% of ULPA filter consumption, highlighting the critical need for ultra‑clean environments in drug formulation and sterile processing areas. Electronics cleanroom demand represented about 42% of total deployments due to precision manufacturing requirements. Biotechnology and medical applications together consumed millions of units, reflecting the reliance on ULPA filtration where product quality cannot be compromised. These stringent requirements ensure that ULPA filters remain a primary selection in advanced cleanroom environments globally. The impact of contamination control regulations extends beyond performance requirements, driving total installed filter volumes. Facility upgrades and automation initiatives in semiconductor fabrication plants drove approximately 1.8 million new ULPA installations in 2024. Pharmaceutical and biotech facilities also expanded cleanroom capacity, leading to tangible increases in ULPA filter adoption, where particle counts must remain low to protect sterile products and research integrity. Industries requiring zero tolerance for sub‑micron contaminants thus continue to prioritize ULPA filter integration into their air handling and laminar flow systems, reinforcing the persistent influence of contamination standards on market expansion.

RESTRAINT

"Higher Cost of ULPA Systems"

A significant restraint in the Cleanroom ULPA Filter Market stems from the higher cost of ULPA filter systems relative to other filtration technologies. Manufacturing and maintaining ULPA filters generally incur about 30% higher costs compared with standard HEPA filters, which can be a barrier for industries with tight operational budgets or where ultra‑high contamination control is not mandated. The initial setup of cleanroom air filtration systems, including ULPA filters, involves substantial calibration, housing, and integration expenses, making it challenging for small and medium enterprises to adopt these systems. Additionally, ULPA filters often require more frequent replacement cycles in high‑usage environments, increasing total cost of ownership. In certain regions lacking strict enforcement of air quality standards, companies may opt for less expensive or alternative filtration solutions, reducing ULPA filter market penetration. Industries such as general industrial manufacturing or low‑risk environments often find HEPA or hybrid filtering adequate, limiting the total addressable market for ULPA systems. These factors collectively temper market expansion by restricting adoption where regulatory demands and high‑precision processing are not present.

OPPORTUNITY

"Expansion in Emerging Industrial Economies"

An opportunity within the Cleanroom ULPA Filter Market arises from rapid industrialization in emerging economies which are expanding electronics fabrication, pharmaceutical production, and biotechnology facilities. In Asia‑Pacific alone, approximately 35% share of global ULPA filter deployments was recorded in 2024, driven by large‑scale investments in semiconductor fabs, biotech labs, and medical device cleanrooms. China, Japan, South Korea, and Taiwan collectively operate about 62% of global semiconductor fabrication capacity, directly contributing to sustained demand for high‑efficiency filtration systems. As such, manufacturers have opportunities to expand distribution networks and customize ULPA solutions for diverse cleanroom classifications in these regions. Emerging markets in Southeast Asia, India, and Latin America are likewise expanding pharma and electronics sectors, leading to increasing installations of ULPA filters across ISO Class 5–ISO Class 8 cleanrooms where contamination control is essential. Technological advancements, such as the integration of smart monitoring features for lifecycle management and real‑time air quality analytics, present further opportunities for product differentiation and value addition. Additionally, rising awareness of indoor air quality in healthcare and biotech research facilities encourages broader adoption beyond traditional manufacturing hubs, presenting strategic avenues for market growth.

CHALLENGE

"Supply Chain Disruptions and Raw Material Volatility"

A key challenge confronting the Cleanroom ULPA Filter Market involves global supply chain disruptions and volatility in raw materials. The production of advanced ULPA filter media often relies on specialized synthetic fibers and coated glass microfibers, whose availability and price can fluctuate based on supply chain constraints. These disruptions can lead to extended lead times and increased inventory costs for manufacturers and end‑users, particularly in industries with tight production schedules like semiconductor and pharmaceutical fabrication. Moreover, geopolitical tensions and trade restrictions on critical materials can impact production continuity, affecting ULPA filter availability in key regions. These challenges require manufacturers to adopt strategic sourcing, maintain buffer inventories, and optimize supply chains to mitigate risk. The potential for supply instability thus adds complexity to maintaining steady production and deployment of ULPA filtration systems across global cleanroom environments, impacting total market responsiveness and timely delivery for sensitive applications.

Cleanroom ULPA Filter Market Segmentation  

Download Free Sample to learn more about this report.

The Cleanroom ULPA Filter Market Segmentation by type and application shows that normal temperature ULPA filters dominate units shipped in standard ISO cleanrooms, whereas high temperature ULPA filters serve extreme process conditions. Application segmentation reveals electronics, pharmaceutical, biotech, and medical device cleanrooms accounting for the majority of installations. Electronics and pharma collectively represent over 75% of installed units in 2024, with biotech and medical sectors adding significant contributions, supported by thousands of new cleanroom projects in advanced manufacturing and life sciences. This segmentation analysis provides key insight into where ULPA demand is highest and which industry verticals are driving deployments.

BY TYPE

Normal Temperature ULPA Filters: Normal temperature ULPA filters are the most widely deployed segment in the Cleanroom ULPA Filter Market, with an estimated 60–70% share of total ULPA filter units used globally. These filters are engineered to operate efficiently in cleanroom environments where processes do not generate high thermal loads, such as pharmaceutical filling suites, electronics assembly cleanrooms, and research laboratories. In 2024 alone, normal temperature ULPA filters accounted for millions of units deployed, outpacing high temperature variants by a substantial margin due to broader applicability. These filters are manufactured using glass microfibers and synthetic media that achieve ultra‑low penetration efficiencies while maintaining stable airflow and low pressure drop. Their dominance reflects broad applicability across various ISO cleanroom classifications ranging from ISO Class 5 to ISO Class 8 standards, where contamination control is essential but temperature stresses are moderate. Industries such as semiconductor fabs, pharmaceutical manufacturing facilities, and biotech research labs rely heavily on this filter type, driving consistent ordering and replacement cycles. Normal temperature ULPA filters are also easier to integrate into conventional HVAC and laminar flow units, contributing to their widespread use in cleanroom expansions and upgrades.

High Temperature ULPA Filters: High temperature ULPA filters, designed to withstand sustained heat exposure and thermal cycling without degradation of filtration media, represent the remaining 30–40% share of the Cleanroom ULPA Filter Market. These filters are critical in cleanroom environments where high process temperatures are present, such as certain aerospace component production, high‑temperature materials research labs, and specialized semiconductor process zones where furnaces or thermal chambers are integrated within controlled air spaces. In 2024, these filters were less numerous than standard temperature variants but maintained strong demand in industries where thermal resilience is mandatory. The construction of high temperature ULPA filters often incorporates reinforced media and metallic grids that maintain filtration efficiency at elevated temperatures up to 150–180°C, enabling continuous operation without structural compromise. While they are more expensive and require specialized housings, their ability to sustain ultra‑low particulate air quality under thermal stress makes them indispensable in advanced manufacturing applications. Research institutions and aerospace labs deploying sensitive thermal processes contribute significantly to this segment’s installed base, compensating for its smaller share with high value and mission‑critical applications.

BY APPLICATION

Electronics Cleanroom: Electronics manufacturing remains the largest application segment within the Cleanroom ULPA Filter Market, accounting for approximately 42% of global ULPA filter installations in 2024. Cleanrooms used for semiconductor fabrication, microelectronics assembly, and precision component production demand ultra‑low contamination conditions where even minute particles can compromise yield and performance. The semiconductor sector alone deployed more than 3.1 million ULPA filters in ISO Class 1–10 cleanrooms in 2024, with Taiwan, South Korea, and Japan each contributing significant volumes due to extensive semiconductor production capacities. Electronics cleanrooms rely on ULPA filters installed in air handling units, laminar flow hoods, and isolation enclosures to maintain stringent particle counts required for advanced chip nodes and high‑precision electronics assembly. In addition to microelectronics fabs, the segment includes cleanrooms used in display manufacturing, optical component production, and precision sensor fabrication, where particulate control directly influences product quality and operational reliability. These environments often integrate ULPA filtration in combination with HEPA stages to achieve the highest air purity levels, making this application the most robust demand center in the market.

Pharmaceutical: The pharmaceutical industry is a major application area for ULPA filters within cleanroom environments, consuming an estimated more than 4.1 million filters worldwide in 2024, representing roughly 30–35% of market share. Pharmaceutical cleanrooms, especially those designated for sterile drug formulation, injectable products, biologics, and vaccine fill‑finish operations, require ultra‑high air quality to prevent contamination that could compromise patient safety. Cleanrooms categorized under ISO Class 5 and ISO Class 7 frequently incorporate ULPA filtration systems in air handling units, isolators, and laminar flow cabinets, where maintaining consistent low particulate counts is critical. The stringent regulatory environment governing pharmaceutical manufacturing necessitates superior filtration capability, prompting facilities to invest in ULPA filters that deliver particle removal at 99.9995% efficiency for particles down to 0.12 microns. Additional drivers include the expansion of biosimilar production facilities and sterile pharmaceutical contract manufacturing organizations (CMOs), which have collectively increased the number of ULPA filter installations in controlled environments. These filters are often subject to regular replacement cycles to uphold manufacturing integrity and compliance with quality standards, reinforcing their steady demand in pharmaceutical cleanrooms.

Biotech: In Cleanroom ULPA Filter Market Research Reports, the biotechnology segment accounted for significant ULPA demand in 2024, consuming more than 1.6 million filters. Biotech cleanrooms are essential in research labs, biosafety level facilities, cell and gene therapy production zones, and biologics manufacturing spaces where air purity at the sub‑micron level is paramount. These environments often operate under tight contamination control regimes, necessitating ULPA filters in air handling units, isolators, and workstation enclosures to maintain particle levels that meet stringent standards. In China alone, biotech facilities installed over 520,000 ULPA filters in 2024 for vaccine production and biologics research cleanrooms. The sector’s growth is driven by rising investments in novel therapeutics and biologics pipelines that require precise and sterile air environments for experimental and production activities. ULPA filters in these applications not only capture ultrafine aerosols and particulate contaminants but also maintain airflow consistency critical to sensitive biological processes. This trend reflects the importance of high‑efficiency filtration in safeguarding product quality and experimental validity in advanced biotechnology applications.

Medical Cleanroom: The medical device industry accounted for over 2.7 million ULPA filter units installed in cleanroom environments in 2024, reflecting its role as a crucial application area within the Cleanroom ULPA Filter Market. Cleanrooms used in medical device manufacturing produce implantable components, surgical instruments, diagnostic equipment, and precision healthcare technologies where particulate contamination can lead to product failure. Medical cleanrooms frequently operate at ISO Class 7 or stricter classifications to ensure the highest quality standards. In these environments, ULPA filters provide critical filtration efficiency capable of capturing sub‑micron particles that HEPA filters may miss, making them essential for maintaining sterile conditions. The segment is further supported by increasing investments in medical technology development facilities, particularly in North America and Europe, where regulatory requirements for quality and sterility are rigorous. ISO Class 8 cleanrooms used for device assembly and packaging also incorporate ULPA filtration in conjunction with robust environmental control systems to safeguard product consistency. The unit demand in this application reflects the sector’s emphasis on patient safety and product reliability, driving continuous adoption of high‑efficiency air filtration solutions.

Cleanroom ULPA Filter Market Regional Outlook

Download Free Sample to learn more about this report.

The Cleanroom ULPA Filter Market Outlook varies significantly by region. Asia‑Pacific leads in ULPA deployment with approximately 35% share of global units consumed, driven by electronics and pharmaceutical facility expansion. North America holds about 28% share, supported by semiconductor fabs and medical cleanrooms. Europe accounts for around 23% of installations, emphasizing regulatory compliance and advanced manufacturing. Middle East & Africa holds roughly 6% of global ULPA filter usage, growing due to healthcare infrastructure investment and regional manufacturing hubs. Each region’s performance reflects distinct industrial priorities, cleanroom classifications, and expansion projects across sectors that demand ultra‑low particulate control.

NORTH AMERICA

North America’s Cleanroom ULPA Filter Market is characterized by extensive deployment of high‑efficiency filtration solutions across semiconductor fabs, pharmaceutical cleanrooms, and medical device manufacturing hubs. The region’s share of ULPA filter installations in 2024 is approximately 28% of the global total, underpinned by strong domestic demand in the United States and Canada. North America continues to invest in semiconductor fabrication lines where particulate control is critical for achieving high yields, particularly in advanced technology nodes where even microscopic contamination can lead to defects. Cleanrooms classified under ISO Class 5–ISO Class 7 are standard in these facilities, requiring ULPA filters capable of capturing sub‑micron contaminants with efficiencies up to 99.9995%. North American companies prioritize advanced filtration technologies with integration into smart monitoring systems for lifecycle management, representing over 25% adoption of ULPA units with performance tracking features. This trend reflects the region’s focus on operational efficiency and compliance with rigorous quality standards. Overall, North America’s strong industrial base across electronics, pharmaceuticals, and medical technology sustains robust ULPA filter demand.

EUROPE

Europe’s Cleanroom ULPA Filter Market accounts for roughly 23% of global ULPA filter deployments, driven by pharmaceutical manufacturing, medical device production, and advanced industrial research facilities. Germany, France, the United Kingdom, and Italy are key markets where stringent environmental and quality standards mandate ultra‑low particulate air filtration. In pharmaceutical cleanrooms, ULPA filters are essential for maintaining contamination control in ISO Class 5–ISO Class 7 environments used for sterile drug formulation, biologics, and vaccine production. Europe’s pharmaceutical manufacturing footprint supports millions of ULPA filter installations annually, reflecting regulatory emphasis on product integrity and patient safety. Medical cleanroom applications also contribute significantly to ULPA filter usage, with hundreds of thousands of units used in facilities producing precision surgical tools, implantable devices, and diagnostic technologies. Cleanrooms in biotech facilities, research institutions, and biosafety labs further elevate demand, particularly in areas focused on cell and gene therapies where ultra clean environments are critical for experimental fidelity. Across the region, regulatory frameworks encourage frequent filter validation and replacement cycles to ensure optimal performance. Smart filtration systems with real‑time monitoring now represent a growing share of installations, supporting efficient asset management in cleanroom operations. Overall, Europe’s diversified industrial base, regulatory focus, and advanced manufacturing ecosystems sustain a steady and technically sophisticated ULPA filter market.

ASIA‑PACIFIC

The Asia‑Pacific Cleanroom ULPA Filter Market leads global deployment with approximately 35% share of ULPA filter installations in 2024, driven by rapid expansion in semiconductor facilities, pharmaceutical manufacturing, and biotechnology research labs. Countries such as China, Japan, South Korea, and Taiwan operate roughly 62% of global semiconductor fabrication capacity, directly contributing to millions of ULPA filter units installed in cleanrooms classified ISO Class 1–ISO Class 7. Electronics cleanroom demand remains the single largest driver of ULPA filter usage in the region, with over 3.1 million units deployed in semiconductor fabs and precision electronics assembly cleanrooms in 2024. Pharmaceutical facilities in Asia‑Pacific also represent a major application area, as regulatory authorities strengthen contamination control standards. India and China have collectively installed millions of filters in sterile pharmaceutical cleanrooms, particularly for injectable drugs and biologics, reflecting the region’s growing pharmaceutical export markets. Biotech laboratories focusing on biologics, biosafety level research, and vaccine production also contribute to regional demand, with combined installations exceeding 1 million ULPA filters in 2024. Smart filter technologies with performance monitoring capabilities have gained traction in Asia‑Pacific, particularly in large fabs where operational efficiency and predictive maintenance are priorities. The region’s strong industrial growth, combined with investments in cleanroom infrastructure across critical sectors, positions it as the dominant hub for Cleanroom ULPA Filter Market activity.

MIDDLE EAST & AFRICA

Middle East & Africa’s Cleanroom ULPA Filter Market holds an estimated 6% share of global ULPA installations, reflecting emerging development in healthcare, pharmaceuticals, and industrial cleanrooms. While smaller than leading regions, Middle East & Africa has seen notable increases in ULPA filter deployments due to expanding healthcare infrastructure, increased pharmaceutical manufacturing zones, and growing commercial cleanroom construction in data centers and aerospace projects. Industrial applications, such as optics assembly and microelectronics maintenance facilities, also contribute to ULPA filter demand in the Middle East & Africa, where dedicated cleanrooms support precision manufacturing processes. An increase in certified cleanroom facilities in industrial free zones has bolstered regional unit consumption. Although absolute volumes remain lower compared with North America, Europe, or Asia‑Pacific, the trajectory of ULPA filter deployment in Middle East & Africa shows steady growth as more facilities adopt advanced contamination control systems. Regional investments in cleanroom infrastructure highlight growing recognition of filtration technologies’ importance in maintaining product quality and regulatory compliance across healthcare and manufacturing sectors.

List of Top Cleanroom ULPA Filter Companies

• Camfil
• CLARCOR
• American Air Filters Company
• MANN+HUMMEL
• Nippon Muki
• Freudenberg
• Daesung
• KOWA air filter
• Trox
• Dafco Filtration
• Haynerair
• Indair
• ZJNF

Top 2 Companies with Highest Market Share

• Camfil: Recognized as a global leader in ULPA filtration with estimated production share holding top close to 25% of global cleanroom ULPA capacity.
• CLARCOR: Ranked among the highest market share holders with manufacturing footprint in North America, Europe, and Asia‑Pacific, contributing to around 20% of global ULPA filter deployments.

Investment Analysis and Opportunities

The Cleanroom ULPA Filter Market Insights reveal substantial investment opportunities aligned with rapid expansion in semiconductor fabs, pharmaceutical manufacturing zones, and biotechnology research facilities worldwide. With ULPA filters capturing approximately 32% of total cleanroom filter units in 2024, demand remains high as industries with stringent contamination control requirements continue to grow. Investors evaluating the Cleanroom ULPA Filter Market Forecast can target regions such as Asia‑Pacific, which accounted for an estimated 35% share of ULPA deployments, supported by large fabrication plants in China, Japan, South Korea, and Taiwan. Considerable capital expenditures in new semiconductor plants, biotechnology labs, and sterile drug manufacturing facilities are driving long‑term filter orders and aftermarket replacement cycles.

In North America, companies procuring ULPA systems for pharmaceuticals and medical device cleanrooms present opportunities for specialized filter manufacturers to introduce advanced media technologies and smart monitoring features. Nearly 25% of new ULPA installations now include real‑time performance analytics, highlighting investor interest in value‑added products. In Europe, stringent regulatory requirements and quality standards in pharma and electronics sectors sustain consistent demand, making this region attractive for strategic partnerships and local production investments. Emerging markets in Southeast Asia, India, and Africa represent untapped potential as cleanroom infrastructure grows in life sciences and precision manufacturing. Investments targeting localized manufacturing, supply chain resilience, and technology integration (e.g., smart filters, nanofiber media) are likely to yield strong ROI as industrial growth accelerates. The evolving Cleanroom ULPA Filter Market Opportunities position filter technologies as essential components of high‑purity environment solutions, supporting long‑term demand across multiple high‑growth sectors.

New Product Development

Innovation within the Cleanroom ULPA Filter Market Research Report has accelerated in response to increasing demand for sustainable and high‑efficiency filtration solutions. In 2023 and 2024, manufacturers introduced ULPA filters with advanced nanofiber media capable of capturing ultrafine particles down to 0.12 microns while reducing energy consumption through lower pressure drops, appealing to facilities focused on operational efficiency. Smart ULPA filters with integrated sensors that monitor differential pressure and predict end‑of‑life thresholds now comprise approximately 28% of new installations, enabling automated maintenance scheduling and reduced downtime.

Development of custom ULPA filter variants designed for specific ISO cleanliness classes — including modular formats for ISO Class 5 and ISO Class 7 environments — has increased by over 25% in product catalogs, allowing end‑users to match performance specs precisely with cleanroom requirements. High temperature ULPA filters engineered to withstand thermal stress up to 150°C have gain